429 related articles for article (PubMed ID: 35127375)
1. Symphony of nanomaterials and immunotherapy based on the cancer-immunity cycle.
Li Q; Shi Z; Zhang F; Zeng W; Zhu D; Mei L
Acta Pharm Sin B; 2022 Jan; 12(1):107-134. PubMed ID: 35127375
[TBL] [Abstract][Full Text] [Related]
2. Extracellular-Vesicle-Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer-Immunity Cycle.
Yong T; Wei Z; Gan L; Yang X
Adv Mater; 2022 Dec; 34(52):e2201054. PubMed ID: 35726204
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
Yang J; Zhang C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
[TBL] [Abstract][Full Text] [Related]
4. Nanomaterials as Smart Immunomodulator Delivery System for Enhanced Cancer Therapy.
Yuan C; Liu Y; Wang T; Sun M; Chen X
ACS Biomater Sci Eng; 2020 Sep; 6(9):4774-4798. PubMed ID: 33455212
[TBL] [Abstract][Full Text] [Related]
5. Immunoengineering with biomaterials for enhanced cancer immunotherapy.
Xie YQ; Wei L; Tang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1506. PubMed ID: 29333729
[TBL] [Abstract][Full Text] [Related]
6. Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future.
Sen S; Won M; Levine MS; Noh Y; Sedgwick AC; Kim JS; Sessler JL; Arambula JF
Chem Soc Rev; 2022 Feb; 51(4):1212-1233. PubMed ID: 35099487
[TBL] [Abstract][Full Text] [Related]
7. Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy.
Zhou L; Zhang P; Wang H; Wang D; Li Y
Acc Chem Res; 2020 Sep; 53(9):1761-1772. PubMed ID: 32819102
[TBL] [Abstract][Full Text] [Related]
8. Application of Nanomaterials in Biomedical Imaging and Cancer Therapy.
Siddique S; Chow JCL
Nanomaterials (Basel); 2020 Aug; 10(9):. PubMed ID: 32872399
[TBL] [Abstract][Full Text] [Related]
9. Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death.
Jin F; Liu D; Xu X; Ji J; Du Y
Int J Nanomedicine; 2021; 16():4693-4712. PubMed ID: 34267518
[TBL] [Abstract][Full Text] [Related]
10. Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what?
Zuo S; Song J; Zhang J; He Z; Sun B; Sun J
Theranostics; 2021; 11(15):7471-7487. PubMed ID: 34158861
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches.
Fuchs N; Zhang L; Calvo-Barreiro L; Kuncewicz K; Gabr M
J Pers Med; 2024 Jan; 14(1):. PubMed ID: 38248769
[TBL] [Abstract][Full Text] [Related]
13. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.
Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ
Acta Pharmacol Sin; 2020 Jul; 41(7):986-994. PubMed ID: 32317755
[TBL] [Abstract][Full Text] [Related]
14. Light-activated nanomaterials for tumor immunotherapy.
Wang F; Duan H; Xu W; Sheng G; Sun Z; Chu H
Front Chem; 2022; 10():1031811. PubMed ID: 36277335
[TBL] [Abstract][Full Text] [Related]
15. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
[TBL] [Abstract][Full Text] [Related]
16. Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment.
Yu S; Wang Y; He P; Shao B; Liu F; Xiang Z; Yang T; Zeng Y; He T; Ma J; Wang X; Liu L
Front Oncol; 2022; 12():809304. PubMed ID: 35198442
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
[TBL] [Abstract][Full Text] [Related]
18. [Immunogenic cell death in hematological malignancies].
Matsushita M
Rinsho Ketsueki; 2021; 62(7):709-716. PubMed ID: 34349052
[TBL] [Abstract][Full Text] [Related]
19. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
Qi J; Jin F; Xu X; Du Y
Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
[TBL] [Abstract][Full Text] [Related]
20. Advances in Engineered Polymer Nanoparticle Tracking Platforms towards Cancer Immunotherapy-Current Status and Future Perspectives.
Thangam R; Patel KD; Kang H; Paulmurugan R
Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
